PMC:7597510 / 1040-1352 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":221,"end":232},"obj":"Body_part"},{"id":"T5","span":{"begin":241,"end":252},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma82780"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma82816"}],"text":"syndrome (GBS) is an acute type of polyradiculoneuropathy, that occurs following immune events such as infection and vaccination. Approximately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases. The cause is"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T19","span":{"begin":10,"end":13},"obj":"Disease"},{"id":"T20","span":{"begin":35,"end":57},"obj":"Disease"},{"id":"T21","span":{"begin":103,"end":112},"obj":"Disease"},{"id":"T22","span":{"begin":155,"end":158},"obj":"Disease"},{"id":"T23","span":{"begin":183,"end":192},"obj":"Disease"}],"attributes":[{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0006915"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"syndrome (GBS) is an acute type of polyradiculoneuropathy, that occurs following immune events such as infection and vaccination. Approximately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases. The cause is"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":221,"end":232},"obj":"Chemical"},{"id":"T2","span":{"begin":241,"end":252},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_33563"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"}],"text":"syndrome (GBS) is an acute type of polyradiculoneuropathy, that occurs following immune events such as infection and vaccination. Approximately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases. The cause is"}

{"project":"LitCovid-PubTator","denotations":[{"id":"47","span":{"begin":241,"end":252},"obj":"Chemical"},{"id":"49","span":{"begin":35,"end":57},"obj":"Disease"},{"id":"50","span":{"begin":103,"end":112},"obj":"Disease"},{"id":"51","span":{"begin":183,"end":192},"obj":"Disease"}],"attributes":[{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:D005732"},{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"MESH:D011129"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"MESH:D007239"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"syndrome (GBS) is an acute type of polyradiculoneuropathy, that occurs following immune events such as infection and vaccination. Approximately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases. The cause is"}

{"project":"LitCovid-sentences","denotations":[{"id":"T12","span":{"begin":130,"end":299},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"syndrome (GBS) is an acute type of polyradiculoneuropathy, that occurs following immune events such as infection and vaccination. Approximately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases. The cause is"}